Cargando…

Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: KRAS plays an important role in transmitting signals from growth factors on the outside of the cell to the cell nucleus. It regulates cell proliferation, growth, and survival. The activation of KRAS occurs in multiple tumour types, either directly due to a mutation in the KRAS gene o...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Sullivan, Éabha, Keogh, Anna, Henderson, Brian, Finn, Stephen P., Gray, Steven G., Gately, Kathy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046549/ https://www.ncbi.nlm.nih.gov/pubmed/36980522 http://dx.doi.org/10.3390/cancers15061635

Ejemplares similares

Realities of KRAS-mutated non-small cell lung cancer
por: Min, Young Joo
Publicado: (2017)

Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer
por: Judd, Julia, et al.
Publicado: (2021)

Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk
por: Wing, Sam E., et al.
Publicado: (2022)

Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Biochip-Based Detection of KRAS Mutation in Non-Small Cell Lung Cancer
por: Kriegshäuser, Gernot, et al.
Publicado: (2011)

Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer
por: Keogh, Anna, et al.
Publicado: (2022)

Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
por: Sun, Jong-Mu, et al.
Publicado: (2013)

Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance
por: Reita, Damien, et al.
Publicado: (2022)

KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer
por: Eklund, Ella A., et al.
Publicado: (2022)

Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
por: Vaclova, Tereza, et al.
Publicado: (2022)

USO1 expression is dysregulated in non-small cell lung cancer
por: Keogh, Anna, et al.
Publicado: (2022)

Intratumor heterogeneity and tissue distribution of KRAS mutation in non-small cell lung cancer: implications for detection of mutated KRAS oncogene in exhaled breath condensate
por: Kordiak, Jacek, et al.
Publicado: (2018)

Targeting KRAS in Non-Small Cell Lung Cancer
por: Corral de la Fuente, Elena, et al.
Publicado: (2022)

Altered expression of ACOX2 in non-small cell lung cancer
por: Sui, Jane S. Y., et al.
Publicado: (2022)

Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer
por: Saber, Ali, et al.
Publicado: (2016)

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
por: PAPADOPOULOU, EIRINI, et al.
Publicado: (2015)

Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival
por: Amanam, Idoroenyi, et al.
Publicado: (2020)

A Real-World Study in Advanced Non–Small Cell Lung Cancer with KRAS Mutations
por: Lei, Lei, et al.
Publicado: (2019)

The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer
por: Zhu, Dao Qi, et al.
Publicado: (2022)

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations
por: Passiglia, Francesco, et al.
Publicado: (2018)

Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
por: Désage, Anne-Laure, et al.
Publicado: (2022)

An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)
por: Murphy, Ciara, et al.
Publicado: (2023)

PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
por: Wang, Lei, et al.
Publicado: (2014)

Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
por: Sunaga, Noriaki, et al.
Publicado: (2021)

EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
por: Tomasini, Pascale, et al.
Publicado: (2016)

Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
por: Lee, Seung Eun, et al.
Publicado: (2016)

KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting
por: Nacchio, Mariantonia, et al.
Publicado: (2020)

Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation
por: Wu, Markus Y., et al.
Publicado: (2021)

How to manage KRAS G12C-mutated advanced non-small-cell lung cancer
por: Ricciuti, Biagio, et al.
Publicado: (2022)

KRAS mutated Non‐Small Lung Carcinoma: A Real World Context from the Indian subcontinent
por: Batra, Ullas, et al.
Publicado: (2022)

Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer
por: Shin, Dong Hoon, et al.
Publicado: (2023)

Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer
por: Yagishita, Shigehiro, et al.
Publicado: (2015)

EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2019)

Increased NQO1 but Not c-MET and Survivin Expression in Non-Small Cell Lung Carcinoma with KRAS Mutations
por: Yilmaz, Ahmet, et al.
Publicado: (2014)

Clinical and Metabolic Parameters in Non-Small Cell Lung Carcinoma and Colorectal Cancer Patients with and without KRAS Mutations
por: Yilmaz, Ahmet, et al.
Publicado: (2014)

Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer
por: Nicoś, Marcin, et al.
Publicado: (2015)

Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
por: Lee, Taebum, et al.
Publicado: (2016)

The Frequency of EGFR and KRAS Mutations in the Turkish Population with Non-small Cell Lung Cancer and their Response to Erlotinib Therapy
por: Demiray, A, et al.
Publicado: (2018)

The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021)

Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer
por: Le, Nguyen Quoc Khanh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cu4om9d9if8dogu9j3slcglos6